← Back to search
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
NEW YORK, NY, 10029
UnclaimedClaim this profile (free)
Other Than Small Business
Prime contracting experience
25 records from government sources. Past participation is not evidence of current teaming interest.
| Role | Agency | Description | Vehicle | Obligated | Action date | Period |
|---|---|---|---|---|---|---|
| Prime | Department of Health and Human Services National Institutes of Health | THIS CONTRACT WILL SUPPORT COMPONENT A OF THE COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) PROGRAM TO DESIGN AND EVALUATE INNOVATIVE INFLUENZA VACCINE APPROACHES, BASED ON PRINCIPLES OF INFLUENZA IMMUNITY, THAT ACHIEVE DURABLE, ROBUST | — | $110,865,640 | Sep 28, 2026 | Sep 10, 2019 – Jul 9, 2027 |
| Prime | National Aeronautics and Space Administration National Aeronautics and Space Administration | IDENTIFICATION OF BIOMARKERS AND PATHOLOGICAL MECHANISMS VIA LONGITUDINAL ANALYSIS OF NEUROLOGICAL AND CEREBROVASCULAR RESPONSES TO NEUROTOXIC STRESS USING A MULTI-CELLULAR INTEGRATED MODEL OF THE HUMAN BRAIN | — | $7,427,599 | Sep 24, 2026 | Sep 28, 2022 – Sep 29, 2027 |
| Prime | Department of Health and Human Services Centers for Disease Control and Prevention | DATA CENTER 2 - ISMMS | — | $28,236,624 | Sep 21, 2026 | Sep 29, 2022 – Aug 31, 2027 |
| Prime | Department of Veterans Affairs Department of Veterans Affairs | GME ACADEMIC YEAR 7/1/2021 - 6/30/2022 | — | $653,752 | Sep 17, 2026 | Jul 1, 2021 – Jun 30, 2026 |
| Prime | Department of Veterans Affairs Department of Veterans Affairs | TRANSPLANT SURGEONS | 36C24223D0034USAspending | $440,094 | Sep 8, 2026 | Apr 1, 2024 – Mar 31, 2025 |
| Prime | Department of Health and Human Services National Institutes of Health | BAA RESEARCH AREA 001: DEVELOPMENT OF VACCINE CANDIDATES FOR BIODEFENSE, ANTIMICROBIAL RESISTANT (AMR) INFECTIONS AND EMERGING INFECTIOUS DISEASES | — | $15,898,493 | Sep 8, 2026 | Jun 1, 2023 – May 31, 2028 |
| Prime | Department of Health and Human Services National Institutes of Health | MSSM CEIRR - THIS CONTRACT WILL SUPPORT THE NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE. | — | $73,940,960 | Aug 27, 2026 | Apr 1, 2021 – Mar 24, 2028 |
| Prime | Department of Health and Human Services National Institutes of Health | IGF::OT::IGF NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS) | — | $79,707,539 | Aug 27, 2026 | Jan 9, 2014 – Aug 1, 2022 |
| Prime | Department of Health and Human Services National Institutes of Health | THE NNTC COLLECTS, STORE, AND PROVIDE CLINICAL DATA AND WELL CHARACTERIZED BIOLOGICAL SPECIMENS, INCLUDING POST-MORTEM TISSUE FROM STUDY VOLUNTEERS AND/OR ORGAN DONORS WITH HIV AS WELL AS HIV-NEGATIVE CONTROLS. | — | $12,490,041 | Aug 20, 2026 | Aug 23, 2023 – Aug 22, 2027 |
| Prime | Department of Health and Human Services National Institutes of Health | THE PURPOSE OF THIS CONTRACT IS TO ESTABLISH COLLECTION SITES(S) (I.E., THE NIH NEUROBIOBANK BRAIN AND TISSUE REPOSITORY (NBB)) TO PROVIDE SERVICES THAT WILL ACTIVELY ACQUIRE, RECEIVE, PROCESS, STORE, CURATE, PRESERVE, AND DISTRIBUTE CNS AND RELATED | — | $2,014,747 | Aug 18, 2026 | Nov 1, 2025 – Oct 31, 2026 |
| Prime | Department of Health and Human Services Centers for Disease Control and Prevention | WTCHP CLINICAL CENTER OF EXCELLENCE | — | $186,198,497 | Jul 30, 2026 | Sep 29, 2022 – Sep 28, 2027 |
| Prime | Department of Health and Human Services National Institutes of Health | THE PURPOSE OF THIS CONTRACT IS TO ESTABLISH COLLECTION SITES(S) (I.E., THE NIH BRAIN AND TISSUE REPOSITORY (NBTR)) TO PROVIDE SERVICES THAT WILL ACTIVELY ACQUIRE, RECEIVE, PROCESS, STORE, CURATE, PRESERVE, AND DISTRIBUTE CNS AND RELATED BIOLOGICAL S | — | $12,059,701 | Jun 24, 2026 | Aug 28, 2019 – Oct 31, 2025 |
| Prime | Department of Health and Human Services Centers for Disease Control and Prevention | IGF::OT::IGF:: WORLD TRADE CENTER HEALTH PROGRAM CLINICAL CENTER OF EXCELLENCE SERVICES | — | $125,465,678 | Jun 8, 2026 | Apr 1, 2017 – Sep 30, 2022 |
| Prime | Department of Veterans Affairs Department of Veterans Affairs | TRANSPLANT SURGEONS | 36C24223D0034USAspending | $467,100 | Mar 19, 2026 | Apr 1, 2026 – Mar 31, 2027 |
| Prime | Department of Veterans Affairs Department of Veterans Affairs | BRAIN BANK | — | $510,000 | Aug 15, 2025 | Sep 30, 2022 – Sep 29, 2026 |
| Prime | Department of Defense Department of the Army | THIS CONTRACT RESULTS FROM A BROAD AGENCY ANNOUNCEMENT WITH THE OVERALL OBJECTIVE TO DEVELOP AND STANDARDIZE AN ASSAY FOR EVALUATING IMMUNOMODULATORY ACTIVITIES OF BIOLOGICAL COMPOUNDS. | — | $391,529 | Jun 23, 2025 | Feb 1, 2024 – Feb 28, 2025 |
| Prime | Department of Veterans Affairs Department of Veterans Affairs | TRANSPLANT SURGEONS | 36C24223D0034USAspending | $443,890 | Apr 14, 2025 | Apr 1, 2023 – Mar 31, 2024 |
| Prime | Department of Health and Human Services National Institutes of Health | TO IDENTIFY NOVEL ADJUVANT CANDIDATES THAT CAN BE USED TO AUGMENT THE EFFICACY OF HUMAN VACCINES. | — | $9,013,936 | Jan 13, 2025 | Sep 11, 2019 – Sep 29, 2024 |
| Prime | Department of Defense Department of the Navy | RESEARCH IAW THE SOW, "WMD ECHO DETECTOR." | — | $47,868,057 | Jun 26, 2024 | Apr 1, 2019 – Dec 31, 2024 |
| Prime | Department of Health and Human Services Centers for Disease Control and Prevention | BAA, THE IMPACT OF SARS-COV-2 INFECTION DURING PREGNANCY ON OBSTETRIC AND NEONATAL OUTCOMES | — | $3,562,594 | Jan 31, 2024 | May 22, 2020 – Aug 31, 2022 |
| Prime | Department of Health and Human Services Centers for Disease Control and Prevention | IGF::OT::IGF:: WORLD TRADE CENTER HEALTH PROGRAM - DATA CENTER SERVICES | — | $31,262,664 | Jan 31, 2024 | Apr 1, 2017 – Sep 30, 2022 |
| Prime | Department of Health and Human Services National Institutes of Health | IGF::OT::IGF R&D- MEDICAL: BIOMEDICAL (BASIC RESEARCH) | — | $4,332,503 | Mar 19, 2023 | Aug 26, 2013 – Aug 31, 2019 |
| Prime | Department of Health and Human Services National Institutes of Health | CYTOF AND O-LINK ASSESSMENT IN THE `NCI COVID-19 IN CANCER PATIENTS STUDY' (NCCAPS) | — | $2,712,342 | Dec 20, 2022 | Dec 23, 2020 – Dec 22, 2023 |
| Prime | Department of Veterans Affairs Department of Veterans Affairs | IGF::OT::IGF CALL COVERAGE TRANSPLANT | — | $2,644,440 | Nov 16, 2022 | Nov 2, 2016 – Mar 31, 2022 |
| Prime | Department of Health and Human Services Centers for Disease Control and Prevention | DATA SERVICES TO THE WTC HEALTH PROGRAM | — | $29,654,574 | Aug 30, 2022 | Jul 1, 2011 – Mar 31, 2017 |
Contract vehicles are shown only when present in the source record. Linked award numbers and vehicles open the authoritative record on USAspending.gov.
Subcontracting experience
15 records from government sources. Past participation is not evidence of current teaming interest.
| Role | Agency | Description | Vehicle | Obligated | Action date | Period |
|---|---|---|---|---|---|---|
| Subcontractor | National Aeronautics and Space Administration | FOR THIS PROJECT, SUBRECIPIENT'S TEAM WILL PROVIDE HUMAN ES CELLS CARRYING THE H2BGFP REPORTER.
THEY WILL ALSO GENERATE MICROGLIA AND OTHER CELL TYPES THAT WILL BE DERIVED FROM HUMAN ES CELLS.
IN ADDITION, THEY WILL HELP WITH THE EXPERIMENTAL DESIGN AND INTERPRETATION OF DATA RELATED TO
INFLAMMATION-MEDIATED NEURODEGENERATION. MOD#04 $49,719.00 Parent award context Parent award agency: National Aeronautics and Space Administration · National Aeronautics and Space Administration Parent award NAICS: 541715 Parent award performance state: MA Parent award description: BIOENGINEER LONG-LASTING 3D NEUROVASCULAR MICROPHYSIOLOGICAL SYSTEM TO MODEL CHRONIC INFLAMMATION-MEDIATED NEURODEGENERATION View parent award on USAspending | — | $49,719 | Jul 22, 2026 | — – — |
| Subcontractor | National Aeronautics and Space Administration | FOR THIS PROJECT, SUBRECIPIENT'S TEAM WILL PROVIDE HUMAN ES CELLS CARRYING THE H2BGFP REPORTER. THEY WILL ALSO GENERATE MICROGLIA AND OTHER CELL TYPES THAT WILL BE DERIVED FROM HUMAN ES CELLS. IN ADDITION, THEY WILL HELP WITH THE EXPERIMENTAL DESIGN AND INTERPRETATION OF DATA RELATED TO INFLAMMATION-MEDIATED NEURODEGENERATION. GR2220 AM3 Parent award context Parent award agency: National Aeronautics and Space Administration · National Aeronautics and Space Administration Parent award NAICS: 541715 Parent award performance state: MA Parent award description: BIOENGINEER LONG-LASTING 3D NEUROVASCULAR MICROPHYSIOLOGICAL SYSTEM TO MODEL CHRONIC INFLAMMATION-MEDIATED NEURODEGENERATION View parent award on USAspending | — | $50,000 | Oct 16, 2025 | — – — |
| Subcontractor | National Aeronautics and Space Administration | FOR THIS PROJECT, SUBRECIPIENT'S TEAM WILL PROVIDE HUMAN ES CELLS CARRYING THE H2BGFP REPORTER. THEY WILL ALSO GENERATE MICROGLIA AND OTHER CELL TYPES THAT WILL BE DERIVED FROM HUMAN ES CELLS. IN ADDITION, THEY WILL HELP WITH THE EXPERIMENTAL DESIGN AND INTERPRETATION OF DATA RELATED TO INFLAMMATION-MEDIATED NEURODEGENERATION. GR2220 AM2 Parent award context Parent award agency: National Aeronautics and Space Administration · National Aeronautics and Space Administration Parent award NAICS: 541715 Parent award performance state: MA Parent award description: BIOENGINEER LONG-LASTING 3D NEUROVASCULAR MICROPHYSIOLOGICAL SYSTEM TO MODEL CHRONIC INFLAMMATION-MEDIATED NEURODEGENERATION View parent award on USAspending | — | $49,179 | Aug 26, 2025 | — – — |
| Subcontractor | Department of Health and Human Services | DEVELOP AND ADVANCE A DURABLE CROSS-PROTECTIVE ADJUVANTED H5N1 AND H5N2 SUBUNIT VACCINES. PG25-61438-05 Parent award context Parent award agency: Department of Health and Human Services · National Institutes of Health Parent award NAICS: 541512 Parent award performance state: MT Parent award description: DEVELOPMENT OF UM-1098: A NOVEL SYNTHETIC TH17 INDUCING ADJUVANT AND DELIVERY SYSTEM View parent award on USAspending | — | $575,022 | Feb 6, 2025 | — – — |
| Subcontractor | Department of Health and Human Services | SUBCONTRACTOR SHALL CONTINUE TO ADDRESS UNMET NEEDS IN SARS-COV-2 SEROLOGICAL TESTING AND RESEARCH THROUGH INVESTIGATION OF CHARACTERISTICS OF
THE IMMUNE RESPONSE THAT CORRELATE WITH PROTECTION FROM INFECTION OR SEVERE DISEASE, WITH A FOCUS ON CANCER PATIENTS. LONGITUDINAL STUDIES SHALL CONTINUE ONLY IN THE MULTIPLE
MYELOMA COHORT; IN HEMATOLOGICAL CANCER TRANSPLANT RECIPIENTS (WITH AND WITHOUT HIV)AND WITH HEALTHY CONTROLS TO ACHIEVE MATCHED TIME POINTS. THIS WORK WILL BE CONDUCTED IN PARTNERSHIP WITH SERONET; INCLUDING THE FNLCR SEROLOGY LABORATORY; AND THE SSC; TO
DEVELOP AND PROVIDE REAGENTS AND STANDARDS TO THE SEROLOGY COMMUNITY ONCE GENERATED AND QUALIFIED. TECHNOLOGY DEVELOPMENT INCLUDES CONDUCTING A PILOT TO ADDRESS THE POSSIBILITY OF INCREASED INCIDENCE OF CANCER DUE TO SARS-COV-2 AS WELL AS COLLECTIONS FROM NOVEL VACCINE RECIPIENTS. 21X092F1 MOD 14 Parent award context Parent award agency: Department of Health and Human Services · National Institutes of Health Parent award NAICS: 541715 Parent award performance state: MD Parent award description: CENTER FOR SEROLOGICAL SCIENCES NETWORK (SERONET) View parent award on USAspending | 75N91019D00024USAspending | $13,096,439 | Nov 1, 2024 | — – — |
| Subcontractor | Department of Health and Human Services | THE OBJECTIVE OF THE FOLLOWING PUBLIC HEALTH INVESTIGATIONS IS
TO DETERMINE THE ANTI-SARS-COV-2 ANTIBODY LEVELS AND SARS-COV-2 TOTAL NEUTRALIZING ANTIBODY
PREVIOUSLY EXPOSED TO SARS-COV-2 AND/OR VACCINATED
WITH CURRENT COVID-19 VACCINES, USING VALIDATED SARS-COV-2 SEROLOGICAL ASSAYS WITH EVIDENCE OF
HIGH SPECIFICITY AND SENSITIVITY.
STUDY 1: IN THE NCI COVID-19 IN CANCER PATIENTS STUDY (NCCAPS) PATIENTS, THE PLAN IS TO INVESTIGATE
LONGITUDINAL ANTIBODY RESPONSE TO SARS-COV-2 INFECTION AND VACCINATION.
STUDY 2: IN THE NCI CLINICAL CENTER STUDY, THE OBJECTIVE IS TO INVESTIGATE THE SAFETY AND
IMMUNOGENICITY OF THE COVID-19 VACCINE (MRNA-1273) IN PARTICIPANTS WITH HEMATOLOGIC
MALIGNANCIES AND VARIOUS REGIMENS OF IMMUNOSUPPRESSION AND IN PARTICIPANTS WITH SOLID TUMORS
ON PD1/PDL1 INHIBITOR THERAPY, INCLUDING BOOSTER DOSES OF VACCINE.
STUDY 3: IN THE CHILDREN'S ONCOLOGY GROUP (COG) STUDY, THE OBJECTIVE IS TO EVALUATE IMMUNOLOGIC RESPONSE FOLLOWING COVID-19 VACCINATION IN CHILDREN, ADOLESCENTS AND YOUNG ADULTS WITH CANCER. 21X092F2 MOD 2 Parent award context Parent award agency: Department of Health and Human Services · National Institutes of Health Parent award NAICS: 541715 Parent award performance state: MD Parent award description: CENTER FOR SEROLOGICAL SCIENCES NETWORK (SERONET) View parent award on USAspending | 75N91019D00024USAspending | $100,813,218 | Mar 29, 2024 | — – — |
| Subcontractor | National Aeronautics and Space Administration | FOR THIS PROJECT, SUBRECIPIENT'S TEAM WILL PROVIDE HUMAN ES CELLS CARRYING THE H2BGFP REPORTER. THEY WILL ALSO GENERATE MICROGLIA AND OTHER CELL TYPES THAT WILL BE DERIVED FROM HUMAN ES CELLS. IN ADDITION, THEY WILL HELP WITH THE EXPERIMENTAL DESIGN AND INTERPRETATION OF DATA RELATED TO INFLAMMATION-MEDIATED NEURODEGENERATION. 505282-78050 AM 01 Parent award context Parent award agency: National Aeronautics and Space Administration · National Aeronautics and Space Administration Parent award NAICS: 541715 Parent award performance state: MA Parent award description: BIOENGINEER LONG-LASTING 3D NEUROVASCULAR MICROPHYSIOLOGICAL SYSTEM TO MODEL CHRONIC INFLAMMATION-MEDIATED NEURODEGENERATION View parent award on USAspending | — | $150,000 | Jan 15, 2024 | — – — |
| Subcontractor | Department of Health and Human Services | SUBCONTRACTOR SHALL CONTINUE TO ADDRESS UNMET NEEDS IN SARS-COV-2 SEROLOGICAL TESTING THROUGH 1) ASSAY DEVELOPMENT 2) LARGE SCALE TESTING FOR ANALYSIS OF SERONET SAMPLES 3) INVESTIGATE CHARACTERISTICS OF THE IMMUNE RESPONSE THAT CORRELATE WITH PROTECTION FROM INFECTION OR SEVERE DISEASE. THESE ASSAYS WILL FACILITATE AN
UNDERSTANDING OF THE NATURAL HISTORY OF THE SARS-COV-2 INFECTION; THE NATURE OF THE IMMUNE RESPONSE; AND EMPOWER VACCINE DEVELOPMENT AND IMPLEMENTATION OF VACCINE STRATEGIES AND NEW VACCINE CANDIDATES. THIS WORK WILL BE CONDUCTED IN PARTNERSHIP WITH
SERONET, INCLUDING THE FNLCR SEROLOGY LABORATORY; AND THE SSC; TO DEVELOP AND PROVIDE REAGENTS AND STANDARDS TO THE SEROLOGY COMMUNITY ONCE GENERATED AND QUALIFIED. 21X092F1 MOD 09 Parent award context Parent award agency: Department of Health and Human Services · National Institutes of Health Parent award NAICS: 541715 Parent award performance state: MD Parent award description: CENTER FOR SEROLOGICAL SCIENCES NETWORK (SERONET) View parent award on USAspending | 75N91019D00024USAspending | $11,099,001 | Sep 25, 2023 | — – — |
| Subcontractor | National Aeronautics and Space Administration | FOR THIS PROJECT, SUBRECIPIENT'S TEAM WILL PROVIDE HUMAN ES CELLS CARRYING THE H2BGFP REPORTER. THEY WILL ALSO GENERATE MICROGLIA AND OTHER CELL TYPES THAT WILL BE DERIVED FROM HUMAN ES CELLS. IN ADDITION, THEY WILL HELP WITH THE EXPERIMENTAL DESIGN AND INTERPRETATION OF DATA RELATED TO INFLAMMATION-MEDIATED NEURODEGENERATION. 505282-78050 Parent award context Parent award agency: National Aeronautics and Space Administration · National Aeronautics and Space Administration Parent award NAICS: 541715 Parent award performance state: MA Parent award description: BIOENGINEER LONG-LASTING 3D NEUROVASCULAR MICROPHYSIOLOGICAL SYSTEM TO MODEL CHRONIC INFLAMMATION-MEDIATED NEURODEGENERATION View parent award on USAspending | — | $100,000 | Aug 30, 2023 | — – — |
| Subcontractor | Department of Health and Human Services | THE OBJECTIVE OF THE PUBLIC HEALTH INVESTIGATION IS TO DETERMINE
THE ANTI-SARS-COV-2 ANTIBODY LEVELS AND SARS-COV-2 TOTAL NEUTRALIZING ANTIBODY LEVELS IN INDIVIDUAL€„¢S THAT MAY HAVE BEEN PREVIOUSLY EXPOSED TO SARS-COV-2 AND/OR VACCINATED WITH CURRENT COVID-19 VACCINES, USING VALIDATED SARS-COV-2 SEROLOGICAL ASSAYS WITH EVIDENCE OF HIGH SPECIFICITY AND SENSITIVITY. IN THE NCI
COVID-19 IN CANCER PATIENTS STUDY (NCCAPS) PATIENTS, THE PLAN IS TO INVESTIGATE LONGITUDINAL ANTIBODY
RESPONSE TO SARS-COV-2 INFECTION AND VACCINATION. 21X092F2 Parent award context Parent award agency: Department of Health and Human Services · National Institutes of Health Parent award NAICS: 541715 Parent award performance state: MD Parent award description: CENTER FOR SEROLOGICAL SCIENCES NETWORK (SERONET) View parent award on USAspending | 75N91019D00024USAspending | $790,860 | Mar 27, 2023 | — – — |
| Subcontractor | Department of Health and Human Services | THE SCOPE OF THIS WORK IS TO PROVIDE A SERIES OF PROTEOGENOMIC ANALYSES IN ORDER TO ENRICH THE SCIENTIFIC
IMPACT OF DATA COLLECTED BY THE CPTAC CONSORTIUM. THE WORK SHALL INCLUDE SAMPLE PREPARATION, PEPTIDE ENRICHMENT, AND ANALYZATION OF THE CANCER GENOME ATLAS (TCGA) BIOSPECIMENS BY MASS
SPECTROMETRY. THE WORK SHALL ALSO FOCUS ON ANALYZING THE CONTRIBUTION OF POSTÂϿ½]TRANSLATIONAL MODIFICATIONS (PTMS) ACROSS CANCER SUBTYPES. WORK IS EXPECTED TO SPAN DEVELOPMENT OF PIPELINES
AND WORKFLOWS FOR ANALYSIS OF THIS DATA, DATA QUALITY CONTROL, ANALYSIS OF DATA, AND REPORTING ANALYSIS
RESULTS. DATA DEPENDENT ACQUISITION (DDA) FOR GLOBAL PROTEOMIC AND PHOSPHOPROTEOMIC DATA FOR ALL
GIVEN SAMPLES SHALL BE PERFORMED. UPDATES WILL BE PROVIDED TO THE LEIDOS BIOMEDICAL RESEARCH, INC.
(LEIDOS BIOMED) TECHNICAL PROJECT MANAGER (TPM) AT MONTHLY TELECONFERENCES TO ENSURE THE WORK IS ON SCHEDULE AND MEETS CPTAC QUALITY STANDARDS. 21X093QF2 Parent award context Parent award agency: Department of Health and Human Services · National Institutes of Health Parent award NAICS: 541715 Parent award performance state: MD Parent award description: N/A View parent award on USAspending | 75N91019D00024USAspending | $550,892 | Mar 23, 2023 | — – — |
| Subcontractor | Department of Health and Human Services | THE OBJECTIVE IS TO ADDRESS UNMET NEEDS IN SARS-COV-2 SEROLOGICAL TESTING: 1) STANDARDIZATION, 2) ASSAY DEVELOPMENT, AND 3) AVAILABILITY OF LARGE-SCALE TESTING TO IDENTIFY THOSE WHO MAY HAVE BEEN
INFECTED OR EXPOSED TO THE VIRUS. SCALING UP OF VALIDATED SARS-COV-2 SEROLOGICAL ASSAYS WITH EMERGENCY USE AUTHORIZATION (EUA) WITH EVIDENCE OF HIGH SPECIFICITY, SENSITIVITY AND
REPRODUCIBILITY, WILL INCREASE NOT ONLY THE NATIONAL TESTING CAPACITY, BUT ALSO ENABLE COMPARISONS OF DATA ACROSS DIFFERENT SITES AND STUDIES. THEREFORE, IT WILL FACILITATE AN UNDERSTANDING OF NATURAL HISTORY OF THE SARS-COV-2 INFECTION, VACCINE DEVELOPMENT, AND IMPLEMENTATION OF NEW VACCINE ANDIDATES. THIS WORK WILL BE CONDUCTED IN PARTNERSHIP WITH SERONET (ACADEMIC AND COMMERCIAL SEROLOGY LABORATORIES), INCLUDING THE FNLCR SEROLOGY LABORATORY, SSNCC AND THE SSC, TO DEVELOP AND MAKE AVAILABLE REAGENTS AND STANDARDS TO THE SEROLOGY COMMUNITY ONCE GENERATED AND QUALIFIED. 21X092F1 MOD 6 Parent award context Parent award agency: Department of Health and Human Services · National Institutes of Health Parent award NAICS: 541715 Parent award performance state: MD Parent award description: CENTER FOR SEROLOGICAL SCIENCES NETWORK (SERONET) View parent award on USAspending | 75N91019D00024USAspending | $2,555,766 | Nov 1, 2022 | — – — |
| Subcontractor | Department of Health and Human Services | THE OBJECTIVE IS TO ADDRESS UNMET NEEDS IN SARS-COV-2 SEROLOGICAL TESTING: 1) STANDARDIZATION, 2) ASSAY DEVELOPMENT, AND 3) AVAILABILITY OF LARGE-SCALE TESTING TO IDENTIFY THOSE WHO MAY HAVE BEEN INFECTED OR EXPOSED TO THE VIRUS. SCALING UP OF VALIDATED SARS-COV-2 SEROLOGICAL ASSAYS WITH EMERGENCY USE AUTHORIZATION (EUA) WITH EVIDENCE OF HIGH SPECIFICITY, SENSITIVITY AND REPRODUCIBILITY, WILL INCREASE NOT ONLY THE NATIONAL TESTING CAPACITY, BUT ALSO ENABLE COMPARISONS OF DATA ACROSS DIFFERENT SITES AND STUDIES. THEREFORE, IT WILL FACILITATE AN UNDERSTANDING OF NATURAL HISTORY OF THE SARS-COV-2 INFECTION, VACCINE DEVELOPMENT, AND IMPLEMENTATION OF NEW VACCINE CANDIDATES. THIS WORK WILL BE CONDUCTED IN PARTNERSHIP WITH SERONET (ACADEMIC AND COMMERCIAL SEROLOGY LABORATORIES), INCLUDING THE FNLCR SEROLOGY LABORATORY, SSNCC AND THE SSC, TO DEVELOP AND MAKE AVAILABLE REAGENTS AND STANDARDS TO THE SEROLOGY COMMUNITY ONCE GENERATED AND QUALIFIED. 21X092F1 MOD 05 Parent award context Parent award agency: Department of Health and Human Services · National Institutes of Health Parent award NAICS: 541715 Parent award performance state: MD Parent award description: CENTER FOR SEROLOGICAL SCIENCES NETWORK (SERONET) View parent award on USAspending | 75N91019D00024USAspending | $312,929 | Sep 27, 2022 | — – — |
| Subcontractor | Department of Health and Human Services | YEAR 1 SITE RESPONSIBILITIES:
€¢ KICKOFF MEETING (BY TELECONFERENCE)
O JUSTIFICATION: REQUIRED FOR COMMUNICATION OF PROJECT GOALS AND EXPECTATION
€¢ ESTABLISHMENT OF THE SURVEILLANCE PROTOCOL AND CASE REPORT FORM INCLUDING RUDIMENTARY TEXT IDENTIFICATION FOR VACCINATION STATUS.
O JUSTIFICATION: SET-UP TIME AND EFFORT COSTS REQUIRED FOR INFORMATION TRANSFER FROM EACH SITE FOR ALL GOALS, WHICH REQUIRES FACE TO FACE MEETINGS, MULTIPLE ZOOM CALLS WITH THE PRIME SITE, AND MULTIPLE TEST RUNS. REQUIRED TO COMMUNICATE WITH OTHER SITES TO BALANCE FEASIBILITY AND RIGOR
€¢ ESTABLISH OR AMEND AGREEMENTS WITH EDNS INSTITUTIONAL REVIEW BOARD (IRB) NON-RESEARCH N/A
€¢ REPORT ESTIMATES OF POPULATIONS SERVED BY EACH HOSPITAL/HOSPITAL NETWORK.
O JUSTIFICATION: REQUIRES SEVERAL MEETINGS TO ESTABLISH SEARCH PARAMETERS AND REVIEW RESULTS
€¢ IRB APPROVAL OF THE SURVEILLANCE PROTOCOL.
O JUSTIFICATION: FOR ALL GOALS, EACH SITE WILL NEED TO MAINTAIN IDENTIFYING INFORMATION ON EACH PATIENT, AND THIS WILL REQUIRE FULL IRB REVIEW. DEVELOP OR MODIFY EXISTING DATA COLLECTION TOOLS AND PROTOCOLS TO SUPPORT THE DATA COLLECTION.
O JUSTIFICATION: REQUIRED TO ESTABLISH FEASIBILITY OF ENSURING COMPLIANCE WITH FEDERAL RULES ON PRIVACY, WHILE ALLOWING LOCAL IDENTIFICATION, AND ENSURING INTERNAL SYSTEMS FOR SWAB TRANSFER TO APPROPRIATE AUTHORITIES
€¢ SUBMIT DRAFT DATA MANAGEMENT PLAN
O JUSTIFICATION: TWO ONE-HOUR ZOOM CALLS TO CREATE METHODS OF API EXTRACTION, DEFINITIONS OF DATA QUALITY, METHODOLOGY FOR TRAINING OF ABSTRACTORS FOR GOAL [6], METHODS FOR REAL- TIME DATA COLLECTION IN GOAL [4], AND PROCEDURES FOR HANDLING OF MISSING DATA.
WEEKLY API MAINTENANCE, UPDATING AND TROUBLESHOOTING, PRE-EXPORT DATA REVIEW, CLEANING AND VERIFICATION AND EXPORT TO REDCAP.
YEAR 2/3 SITE RESPONSIBILITIES
€¢ IRB APPROVAL OF THE SURVEILLANCE PROTOCOL.
O 2 HOURS. PROTOCOL PREPARATION, SUBMISSION AND REVISION
O JUSTIFICATION: FOR ALL GOALS, EACH SITE WILL NEED TO MAINTAIN IDENTIFYING INFORMATION ON EACH PATIENT, AND THIS WILL REQUIRE FULL IRB REVIEW. DEVELOP OR MODIFY EXISTING DATA COLLECTION TOOLS AND PROTOCOLS TO SUPPORT THE DATA COLLECTION.
O JUSTIFICATION: REQUIRED TO ESTABLISH FEASIBILITY OF ENSURING COMPLIANCE WITH FEDERAL RULES ON PRIVACY, WHILE ALLOWING LOCAL RE-IDENTIFICATION, AND ENSURING INTERNAL SYSTEMS FOR SWAB TRANSFER TO APPROPRIATE AUTHORITIES.
WEEKLY API MAINTENANCE, UPDATING AND TROUBLESHOOTING, PRE-EXPORT DATA REVIEW, CLEANING AND VERIFICATION AND EXPORT TO REDCAP. WSU22012 Parent award context Parent award agency: Department of Health and Human Services · Centers for Disease Control and Prevention Parent award NAICS: 541360 Parent award performance state: GA Parent award description: ENHANCING U.S. SURVEILLANCE OF LABORATORY CONFIRMED SARS-COV-2, INFLUENZA, AND OTHER RESPIRATORY VIRUSES View parent award on USAspending | — | $236,812 | Apr 15, 2022 | — – — |
| Subcontractor | Department of Health and Human Services | THE OBJECTIVE IS TO ADDRESS UNMET NEEDS IN SARS-COV-2 SEROLOGICAL TESTING: 1) STANDARDIZATION, 2) ASSAY DEVELOPMENT, AND 3) AVAILABILITY OF LARGE-SCALE TESTING TO IDENTIFY THOSE WHO MAY HAVE BEEN INFECTED OR EXPOSED TO THE VIRUS. SCALING UP OF VALIDATED SARS-COV-2 SEROLOGICAL ASSAYS WITH EMERGENCY USE AUTHORIZATION (EUA) WITH EVIDENCE OF HIGH SPECIFICITY, SENSITIVITY AND REPRODUCIBILITY, WILL INCREASE NOT ONLY THE NATIONAL TESTING CAPACITY, BUT ALSO ENABLE COMPARISONS OF DATA ACROSS DIFFERENT SITES AND STUDIES. THEREFORE, IT WILL FACILITATE AN UNDERSTANDING OF NATURAL HISTORY OF THE SARS-COV-2 INFECTION, VACCINE DEVELOPMENT, AND IMPLEMENTATION OF NEW VACCINE CANDIDATES. THIS WORK WILL BE CONDUCTED IN PARTNERSHIP WITH SERONET (ACADEMIC AND COMMERCIAL SEROLOGY LABORATORIES), INCLUDING THE FNLCR SEROLOGY LABORATORY, SSNCC AND THE SSC, TO DEVELOP AND MAKE AVAILABLE REAGENTS AND STANDARDS TO THE SEROLOGY COMMUNITY ONCE GENERATED AND QUALIFIED. 21X092F1 Parent award context Parent award agency: Department of Health and Human Services · National Institutes of Health Parent award NAICS: 541715 Parent award performance state: MD Parent award description: CENTER FOR SEROLOGICAL SCIENCES NETWORK (SERONET) View parent award on USAspending | 75N91019D00024USAspending | $2,816,359 | Dec 31, 2021 | — – — |
Contract vehicles are shown only when present in the source record. Linked award numbers and vehicles open the authoritative record on USAspending.gov.
Agencies supported
- Department of Veterans AffairsGov-sourced
- Department of Health and Human ServicesGov-sourced
- National Aeronautics and Space AdministrationGov-sourced
- Department of DefenseGov-sourced
Government-sourced data comes from SAM.gov, SBA and USAspending.gov and is attributed to its source. Items marked company-reported were provided by the company and are verified by FedSub only where labeled. FedSub is a private company and is not affiliated with SBA, GSA/SAM.gov, or any government agency.